2024-11-19 00:28:17
Transcenta Announces First Patient Dosed in Phase I Clinical Trial of Claudin18.2 Targeting Monoclonal Antibody TST001 in the US
Health/ 2023-07-22
Transcenta Announces First Patient Dosed...

SUZHOU,China,July 1,2020-- Transcenta Holding Limited ("Transcenta"),a global biotherapeutics company with fully-integrated capabi...

Affinity discovers potent SARS-CoV-2 antibodies
Health/ 2023-07-22
Affinity discovers potent SARS-CoV-2 ant...

MELBOURNE,Australia,July 2,2020-- Melbourne-based Affinity Biosciences Pty Ltd (Affinity),a privately held company focused on antibody disco...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release